Summary
The Cigna Group reported solid top-line growth for the second quarter of 2023, with total revenues increasing by 7% to $48.6 billion, driven by strong performance in both Evernorth Health Services and Cigna Healthcare segments. While the company experienced a slight decrease in shareholders' net income to $1.46 billion from $1.56 billion in the prior year's quarter, this was largely due to lower adjusted income from operations and the absence of earnings from divested businesses. Evernorth Health Services demonstrated robust growth in adjusted revenues, up 10%, fueled by specialty pharmacy and increased client services. Cigna Healthcare also saw a 12% increase in adjusted revenues, supported by customer growth and higher premium rates. The company's capital position remains strong, with significant liquidity and a stable debt-to-capitalization ratio. Strategic investments in healthcare services, including a notable investment in VillageMD, signal continued focus on expanding care delivery capabilities and long-term growth.
Financial Highlights
47 data points| Revenue | $48.59B |
| Cost of Revenue | $33.44B |
| Gross Profit | $15.14B |
| SG&A Expenses | $3.43B |
| Operating Income | $2.22B |
| Interest Expense | $350.00M |
| Net Income | $1.46B |
| EPS (Basic) | $4.96 |
| EPS (Diluted) | $4.92 |
| Shares Outstanding (Diluted) | 296.88M |
Key Highlights
- 1Total revenues increased by 7% year-over-year to $48.6 billion for the second quarter of 2023.
- 2Shareholders' net income slightly decreased to $1.46 billion from $1.56 billion year-over-year, primarily due to a decline in adjusted income from operations.
- 3Evernorth Health Services experienced a 10% increase in adjusted revenues, driven by growth in specialty pharmacy and care delivery solutions.
- 4Cigna Healthcare's adjusted revenues grew by 12%, supported by customer growth and higher premium rates.
- 5The company made a significant strategic investment of $2.7 billion in VillageMD during the first half of 2023.
- 6Cash flows from operating activities were strong at $7.5 billion for the first six months of 2023, a substantial increase from $3.3 billion in the prior year.
- 7The company repurchased $1.1 billion of its common stock in the first six months of 2023, down from $2.3 billion in the same period last year.